CareDx Inc [CDNA] Director makes an insider sale of 5,179 shares worth 119,169.

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. CareDx Inc shares valued at $119,169 were sold by Colon Grace on May 11. At $23.01 per share, Colon Grace sold 5,179 shares. The insider’s holdings dropped to 2,522 shares worth approximately $61284.6 following the completion of this transaction.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Also, Goldberg Michael sold 500 shares, netting a total of over 18,006 in proceeds. Following the sale of shares at $36.01 each, the insider now holds 62,267 shares.

Before that, Maag Peter had sold 10,000 shares from its account. In a trade valued at $386,394, the Director traded CareDx Inc shares for $38.64 each. Upon closing the transaction, the insider’s holdings decreased to 10,000 shares, worth approximately $7.57 million.

As published in their initiating research note from Stephens on April 25, 2022, CareDx Inc [CDNA] has been an Overweight and the price target has been revised to $50. This represents a 51.4% premium over Thursday’s closing price. As of June 03, 2021, Goldman has initiated its “Buy” rating for CDNA. Earlier on February 26, 2021, H.C. Wainwright downgraded its rating. Their new recommendation was “a Neutral” for CDNA stock which previously was a “a Buy”.

Analyzing CDNA’s Price Performance

On Thursday, CareDx Inc [NASDAQ: CDNA] plunged -0.82% to $24.30. The stock’s lowest price that day was $23.96, but it reached a high of $24.975 in the same session. During the last five days, there has been a drop of approximately -0.25%. Over the course of the year, CareDx Inc shares have dropped approximately -46.57%. Shares of the company reached a 52-week high of $47.82 on 01/04/22 and a 52-week low of $19.34 on 06/14/22. A 50-day SMA is recorded $23.69, while a 200-day SMA reached $36.27. Nevertheless, trading volume fell to 1.12 million shares from 0.49 million shares the previous day.

Support And Resistance Levels for CareDx Inc (CDNA)

According to the 24-hour chart, there is a support level at 23.85, which, if violated, would cause prices to drop to 23.40. In the upper region, resistance lies at 24.86. The next price resistance is at 25.43. RSI (Relative Strength Index) is 51.92 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.45, which suggests the price will decrease in the coming days. Percent R is at 37.81%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Is CareDx Inc subject to short interest?

Stocks of CareDx Inc saw a sharp rise in short interest on Jul 14, 2022 jumping by 0.69 million shares to 4.29 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 3.6 million shares. A jump of 16.08% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 5.02 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.02.

Which companies own the most shares of CareDx Inc (CDNA)?

According to The Vanguard Group, Inc. filings, the company currently owns 4,510,146 shares, which is about 8.47% of the total CDNA shares outstanding. The investor’s shares have plunged by -617,210 from its previous 13-F filing of 5127356.0 shares. With the completion of the buy transaction, ARK Investment Management LLC’s stake is now worth $85,822,266. Fred Alger Management LLC acquire a 6.83% interest valued at $75.06 million while BlackRock Fund Advisors sold a -10,204 stake. A total of 745,779 shares of CareDx Inc were sold by SSgA Funds Management, Inc. during the quarter, and 617,264 were bought by ArrowMark Colorado Holdings LLC. In its current portfolio, Bellevue Asset Management AG holds 2,311,176 shares valued at $49.64 million.

In terms of CareDx Inc share price expectations, FactSet research, analysts set an average price target of $49.67 in the next 12 months, up nearly 93.88% from the previous closing price of $24.50. Analysts anticipate CareDx Inc stock to reach $63.00 by 2022, with the lowest price target being $42.00. In spite of this, 7 analysts ranked CareDx Inc stock as a Buy at the end of 2022. On October 30, 2020, H.C. Wainwright assigned a price target of “a Buy” to the stock and reiterated coverage with a $55.

LEAVE A REPLY

Please enter your comment!
Please enter your name here